Table 4.
Correlations Between Clinical Symptoms, the Moral Injury Events Scale (MIES), and Exposure to COVID-19 at Baseline, One Month, and Three Months
Clinical symptoms | |||||
---|---|---|---|---|---|
Day | GAD-7 | PHQ-9 | Suicidal ideation | PC-PTSD | |
MIES | 1 | .56*** | .59*** | .44*** | .42*** |
30 | .50*** | .56*** | .39*** | .48*** | |
90 | .47*** | .47*** | .38*** | .57*** | |
Exposure to COVID-19a | 1 | .15** | .14** | .001 | .22*** |
30 | .04 | .06 | .05 | .05 | |
90 | .06 | .02 | .0 | .07 |
GAD-7 Generalized Anxiety Disorder, PHQ-9 Patient Health Questionnaire, PC-PTSD Primary Care PTSD Screen for DSM-5, MIES Mural Injury Events Scale, an Exposure to COVID-19 were participants who tested positive for COVID-19 or had a close friend/family member who tested positive; ***p < .001; **p < .01